Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis.
Akira OnishiHirotaka YamadaWataru YamamotoRyu WatanabeRyota HaraMasaki KatayamaYasutaka OkitaYuichi MaedaHideki AmuroYonsu SonAyaka YoshikawaKenichiro HataMotomu HashimotoJun SaegusaAkio MorinobuPublished in: Rheumatology (Oxford, England) (2023)
In the analysis with IPW to reduce selection bias, IL-6Ri monotherapy was superior to TNFi monotherapy in terms of effectiveness and drug retention. No significant differences were identified between CTLA4Ig, JAKi, and TNFi monotherapy.